| Ljubisa Micic, MD | |
|
2604 169th St, Flushing, NY 11358-1131 | |
| (347) 438-1950 | |
| (347) 438-1951 |
| Full Name | Ljubisa Micic |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 2604 169th St, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750395000 | NPI | - | NPPES |
| 01894586 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 212787 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crd Associates Llc Cliffside Nursing Home | Flushing, NY | Dialysis facility |
| Atlas Park Dialysis | Glendale, NY | Dialysis facility |
| Flushing Hospital Medical Center | Flushing, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Medical Care Pllc | 3274842224 | 4 |
News Archive
Iowa should debate a key health-reform program in public so the program doesn't get twisted in favor of the insurance industry, consumer-group advocates said today. Legislators last year failed to reach agreement on how to set up a state health-insurance exchange.
Noting "Mitt Romney will become the official nominee for the Republican Party at its convention in Florida" this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition's "Breakthroughs" blog.
"In a fresh sign of divisions in the president's own party," Rep. Mike Ross, D-Ark., on Tuesday came out against including a public insurance plan in health reform legislation, the Associated Press reports. Ross said he could not support a public plan after hearing from constituents during the August recess (Werner, 9/8).
Since the WHO developed Directly Observed Therapy, Short-course (DOTS) in 1994 for the treatment of tuberculosis, approximately 36 million people have successfully completed treatment and been cured over the past 15 years, according to new data released by the WHO on Tuesday, health-e reports (Thom, 12/8).
On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."
› Verified 1 days ago
| Entity Name | Flushing Hospital & Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548217763 PECOS PAC ID: 2668367483 Enrollment ID: O20040219000415 |
News Archive
Iowa should debate a key health-reform program in public so the program doesn't get twisted in favor of the insurance industry, consumer-group advocates said today. Legislators last year failed to reach agreement on how to set up a state health-insurance exchange.
Noting "Mitt Romney will become the official nominee for the Republican Party at its convention in Florida" this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition's "Breakthroughs" blog.
"In a fresh sign of divisions in the president's own party," Rep. Mike Ross, D-Ark., on Tuesday came out against including a public insurance plan in health reform legislation, the Associated Press reports. Ross said he could not support a public plan after hearing from constituents during the August recess (Werner, 9/8).
Since the WHO developed Directly Observed Therapy, Short-course (DOTS) in 1994 for the treatment of tuberculosis, approximately 36 million people have successfully completed treatment and been cured over the past 15 years, according to new data released by the WHO on Tuesday, health-e reports (Thom, 12/8).
On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."
› Verified 1 days ago
| Entity Name | Nephrology Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306222526 PECOS PAC ID: 3274842224 Enrollment ID: O20151014002239 |
News Archive
Iowa should debate a key health-reform program in public so the program doesn't get twisted in favor of the insurance industry, consumer-group advocates said today. Legislators last year failed to reach agreement on how to set up a state health-insurance exchange.
Noting "Mitt Romney will become the official nominee for the Republican Party at its convention in Florida" this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition's "Breakthroughs" blog.
"In a fresh sign of divisions in the president's own party," Rep. Mike Ross, D-Ark., on Tuesday came out against including a public insurance plan in health reform legislation, the Associated Press reports. Ross said he could not support a public plan after hearing from constituents during the August recess (Werner, 9/8).
Since the WHO developed Directly Observed Therapy, Short-course (DOTS) in 1994 for the treatment of tuberculosis, approximately 36 million people have successfully completed treatment and been cured over the past 15 years, according to new data released by the WHO on Tuesday, health-e reports (Thom, 12/8).
On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ljubisa Micic, MD 2604 169th St, Flushing, NY 11358-1131 Ph: (347) 438-1950 | Ljubisa Micic, MD 2604 169th St, Flushing, NY 11358-1131 Ph: (347) 438-1950 |
News Archive
Iowa should debate a key health-reform program in public so the program doesn't get twisted in favor of the insurance industry, consumer-group advocates said today. Legislators last year failed to reach agreement on how to set up a state health-insurance exchange.
Noting "Mitt Romney will become the official nominee for the Republican Party at its convention in Florida" this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition's "Breakthroughs" blog.
"In a fresh sign of divisions in the president's own party," Rep. Mike Ross, D-Ark., on Tuesday came out against including a public insurance plan in health reform legislation, the Associated Press reports. Ross said he could not support a public plan after hearing from constituents during the August recess (Werner, 9/8).
Since the WHO developed Directly Observed Therapy, Short-course (DOTS) in 1994 for the treatment of tuberculosis, approximately 36 million people have successfully completed treatment and been cured over the past 15 years, according to new data released by the WHO on Tuesday, health-e reports (Thom, 12/8).
On-X® Life Technologies, Inc., today announced the publication of results of a large, prospective multi-center Canadian trial with the On-X® Prosthetic Heart Valve in the November issue of The Journal of Thoracic and Cardiovascular Surgery.1 According to the results of the report, "The On-X mechanical prosthesis provides favorable intermediate-term results with regard to major thromboembolism, hemorrhage and composites of valve-related complications."
› Verified 1 days ago
Ms. Min Cai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355 Phone: 718-321-0558 Fax: 718-321-1672 | |
Dr. David Scott Rubin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13847 Horace Harding Expy, Flushing, NY 11367 Phone: 718-461-5813 Fax: 718-321-8095 | |
Xueshu Zhang, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355 Phone: 718-359-5780 Fax: 718-359-5821 | |
Haoxu Ouyang, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355 Phone: 718-269-5055 | |
Mu-i Karen Kuo, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355 Phone: 718-939-6234 Fax: 718-939-6235 | |
Evan Choi, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Mustafa Salehmohamed, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355 Phone: 718-670-1405 |